We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
Cap. Flow
+$1.91B
Cap. Flow %
13.37%
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$139M
2
PG icon
Procter & Gamble
PG
+$118M
3
TFX icon
Teleflex
TFX
+$90.1M
4
MSFT icon
Microsoft
MSFT
+$89.4M
5
UBS icon
UBS Group
UBS
+$77.2M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$203M
2
AGN
Allergan plc
AGN
+$177M
3
MLNX
Mellanox Technologies, Ltd.
MLNX
+$118M
4
AMZN icon
Amazon
AMZN
+$115M
5
LIN icon
Linde
LIN
+$89.1M

Sector Composition

Rank Sector Weight
1 Healthcare 21.29%
2 Consumer Discretionary 15.87%
3 Technology 12.26%
4 Financials 12.01%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPS icon
376
Digital Turbine
APPS
$1.02B
$7.17M 0.05%
570,205
+90,390
+19% +$631K
ACGL icon
377
Arch Capital
ACGL
$36.1B
$7.17M 0.05%
250,131
+220,979
+758% +$6.11M
SBH icon
378
Sally Beauty Holdings
SBH
$1.4B
$7.16M 0.05%
+571,684
New +$6.26M
CIICU
379
DELISTED
CIIG Merger Corp. Units
CIICU
$7.14M 0.05%
700,000
IOSP icon
380
Innospec
IOSP
$2.09B
$7.13M 0.05%
92,313
+27,484
+42% +$2.01M
FEAC.U
381
DELISTED
Flying Eagle Acquisition Corp. Units, each consisting of one share of Class A common stock and one-f
FEAC.U
$6.99M 0.05%
600,000
CTLT
382
DELISTED
CATALENT, INC.
CTLT
$6.99M 0.05%
+95,314
New +$6.47M
CCXI
383
DELISTED
ChemoCentryx, Inc.
CCXI
$6.96M 0.05%
121,003
+108,919
+901% +$5.93M
BF.B icon
384
Brown-Forman Class B
BF.B
$12B
$6.92M 0.05%
108,687
+62,932
+138% +$4.01M
SMMCU
385
DELISTED
South Mountain Merger Corp. Unit
SMMCU
$6.89M 0.05%
650,000
WABC icon
386
Westamerica Bancorp
WABC
$1.39B
$6.89M 0.05%
+119,970
New +$6.98M
PAYC icon
387
Paycom
PAYC
$6.78B
$6.77M 0.05%
+21,861
New +$5.82M
CSX icon
388
CSX Corp
CSX
$98.6B
$6.74M 0.05%
289,872
+283,962
+4,805% +$6.28M
HTLD icon
389
Heartland Express
HTLD
$1.11B
$6.71M 0.05%
+322,464
New +$6.48M
HLF icon
390
Herbalife
HLF
$1.23B
$6.7M 0.05%
148,965
+144,909
+3,573% +$5.63M
EVFM
391
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$6.67M 0.05%
+157,212
New +$10.6M
ENTA icon
392
Enanta Pharmaceuticals
ENTA
$372M
$6.62M 0.05%
131,824
-120,137
-48% -$6.22M
FMX icon
393
Fomento Económico Mexicano
FMX
$43.3B
$6.61M 0.05%
106,521
+104,687
+5,708% +$6.67M
DPZ icon
394
Domino's
DPZ
$11B
$6.59M 0.05%
17,833
+17,725
+16,412% +$6.53M
GAP
395
The Gap Inc
GAP
$6.84B
$6.57M 0.05%
520,226
+213,671
+70% +$1.93M
OC icon
396
Owens Corning
OC
$11.5B
$6.57M 0.05%
117,731
+117,445
+41,065% +$5.47M
TXN icon
397
Texas Instruments
TXN
$255B
$6.56M 0.05%
51,634
+49,302
+2,114% +$5.75M
NTAP icon
398
NetApp
NTAP
$32.9B
$6.53M 0.05%
147,250
+137,851
+1,467% +$5.92M
LEG icon
399
Leggett & Platt
LEG
$1.52B
$6.51M 0.05%
+185,321
New +$5.75M
TLMD
400
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$6.51M 0.05%
650,000

Similar funds

Marshall Wace's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.

  • Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
  • Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
  • Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
  • Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
  • Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
  • Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
  • Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.

Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.